ramosetron has been researched along with Weight Gain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barker, MH; Chasseaud, LF; Gazeley, MJ; Gopinath, C; Healey, GF; Hedge, A; Ince, G; Miki, H; Read, RM; Ruckman, SA; Sakai, T; Suzuki, H; Tabata, H | 1 |
1 other study(ies) available for ramosetron and Weight Gain
| Article | Year |
|---|---|
Oncogenicity studies of the new serotonin (5-HT)3-receptor antagonist ramosetron in mice and rats.
Topics: Animals; Benzimidazoles; Carcinogens; Eating; Female; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred F344; Serotonin Antagonists; Survival; Weight Gain | 1996 |